Recovery after pulmonary embolism can take time, and continued shortness of breath in the following weeks does not automatically mean that a new embolism or chronic pulmonary hypertension is present. In some patients, however, dyspnea, fatigue or reduced exercise capacity persist beyond the acute phase and warrant a structured assessment.
The new 2026 AHA/ACC guidelines recommend checking symptoms and functional limitations at every visit for at least one year after pulmonary embolism, precisely to detect chronic consequences early.
If breathlessness suddenly becomes much more severe, new chest pain, syncope, hemoptysis, marked tachycardia or rapid deterioration in general condition occurs, the scheduled follow-up appointment should not be awaited: a new pulmonary embolism or another acute condition must be ruled out.
The main points to know are:
There is no recovery period that is the same for everyone. After the acute phase, the right ventricle must recover from the sudden increase in pulmonary vascular resistance, thrombi must organize or resolve, and the person must regain strength and physical conditioning after illness, hospitalization and reduced activity.
For this reason, breathlessness may occur during activities that were previously well tolerated in the first few weeks, especially after a major pulmonary embolism.
The situation changes when dyspnea remains unchanged or becomes progressively worse over time and continues to limit daily activities. The term post-pulmonary embolism syndrome is used to describe a spectrum of persistent problems, typically assessed after at least three months of adequate anticoagulant therapy. These may include dyspnea, reduced exercise capacity, functional impairment, persistent right ventricular abnormalities, chronic thromboembolic disease and, in more severe cases, chronic thromboembolic pulmonary hypertension.
Persistent dyspnea is much more common than CTEPH. The most recent studies and guidelines indicate that up to approximately half of patients may report some degree of limitation or shortness of breath after three months, whereas CTEPH develops after acute pulmonary embolism in a minority of patients, on the order of approximately 3%.
Breathlessness after pulmonary embolism may have several causes and often does not result from a single abnormality. One possibility is deconditioning: after weeks of inactivity, even modest exertion requires a larger proportion of the available cardiopulmonary capacity. Obesity, anemia, respiratory diseases, cardiac disorders, arrhythmias or other conditions present before the embolism may also contribute.
In some patients, right ventricular dysfunction persists, or perfusion defects remain in the pulmonary arteries without the development of true pulmonary hypertension at rest. Anxiety and fear of recurrence may also reduce activity and heighten the perception of limitation, but this does not make the symptoms "imaginary": reduced performance after an embolism can be real even when CTEPH is not found.
Recurrent thromboembolism must also be ruled out when the clinical picture makes it plausible. Anticoagulation substantially reduces the risk but does not eliminate it, and the onset of new or markedly worsening symptoms requires a different approach from that used for stable dyspnea present since hospital discharge.
CTEPD, chronic thromboembolic pulmonary disease, refers to a chronic pulmonary thromboembolic condition in which organized vascular abnormalities persist after the acute phase and the patient has symptoms or exercise limitation. CTEPD may occur with or without pulmonary hypertension at rest.
When chronic thromboembolic disease is accompanied by true hemodynamically documented precapillary pulmonary hypertension, it is termed chronic thromboembolic pulmonary hypertension, or CTEPH.
CTEPH is not simply "a thrombus still visible on CT". It is a disease in which chronic pulmonary arterial obstruction and, to varying degrees, remodeling of the small vessels increase the resistance against which the right ventricle must pump.
This distinction matters because both conditions can cause symptoms, but CTEPH has a specific hemodynamic consequence. It is also a particularly important form of pulmonary hypertension to recognize, because targeted treatments are available, including procedures that can remove or bypass chronic obstructions.
Follow-up after pulmonary embolism begins with the medical history and clinical examination: how much the ability to walk, climb stairs or perform usual activities has changed, whether symptoms are improving or worsening, and whether chest pain, syncope, palpitations or signs of congestion are present. Anticoagulation, possible recurrences, anemia and other potential cardiac or respiratory causes are also reassessed.
Echocardiography can identify signs of right ventricular overload or dysfunction and estimate the probability of pulmonary hypertension. However, a normal echocardiogram does not, by itself, explain persistent dyspnea and does not exclude all forms of CTEPD.
A ventilation/perfusion scan plays a central role because it is highly sensitive in identifying perfusion defects compatible with chronic thromboembolic disease. Depending on the findings, dedicated CT pulmonary angiography, specialist imaging and assessment at an expert center may be needed.
Cardiopulmonary exercise testing can be particularly useful when symptoms are genuine but investigations at rest do not explain the limitation. It helps distinguish patterns consistent with deconditioning, heart disease, lung disease or pulmonary vascular abnormalities. When suspicion of CTEPH remains substantial, right heart catheterization can document any precapillary pulmonary hypertension.
Indiscriminately subjecting all asymptomatic patients to a long series of tests is not recommended. Modern follow-up focuses primarily on identifying those with persistent symptoms, new functional limitation or findings that make a chronic complication plausible.
When CTEPH is diagnosed, the patient should be assessed at an expert center for chronic thromboembolic disease. The first question is whether the obstructions are operable by pulmonary endarterectomy. In suitable patients, this procedure can produce very substantial improvement and is the treatment of choice.
For inoperable or residual disease, balloon pulmonary angioplasty and targeted medical therapy may be considered as part of a multimodal strategy.
CTEPD without pulmonary hypertension may also require specialist assessment when symptoms are significant, because mechanical interventions may be considered in selected patients. The decision is complex and does not depend solely on the presence of a perfusion defect on scintigraphy.
If CTEPD and CTEPH are ruled out, assessment should seek other causes of dyspnea. For patients with persistent symptoms not explained by a specific vascular complication, the 2026 AHA/ACC guideline considers a pulmonary rehabilitation program reasonable after at least three months of therapeutic anticoagulation, with the aim of improving exercise tolerance and functional recovery.
Is it normal to still be short of breath after pulmonary embolism?
It can happen. Recovery differs between individuals, and dyspnea or reduced exercise tolerance may persist even without pulmonary hypertension. Symptoms should be reassessed if they fail to improve, worsen or persist after about three months.
When should CTEPH be suspected after pulmonary embolism?
CTEPH should be considered particularly when dyspnea or functional limitation persists or progresses at least three months after the acute episode, especially if there are signs of right ventricular overload or abnormal test findings.
Does residual thrombus on CT mean that CTEPH is present?
No. Residual vascular abnormalities may persist without causing pulmonary hypertension. CTEPH requires compatible clinical, imaging and hemodynamic findings and cannot be diagnosed solely from residual thrombotic material.
Which test is most useful for detecting chronic thromboembolic disease?
Ventilation/perfusion scanning is particularly sensitive for detecting chronic perfusion defects. Echocardiography, CT, exercise testing and, when appropriate, right heart catheterization complete the assessment.
If CTEPH is ruled out, can rehabilitation improve breathlessness?
Yes. Once causes requiring specific treatment have been excluded, a rehabilitation program may improve symptoms and exercise tolerance in patients with deconditioning or post-pulmonary embolism syndrome.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.